Abstract | OBJECTIVE: METHODS: Twenty-five patients with hematological diseases who were diagnosed according to the criteria of European Organization for Research and Treatment of Cancer (EORTC), including 6 cases with confirmed diagnosis diagnosis, 12 cases with clinical diagnosis, and 7 cases with recommended diagnosis, underwent intravenous injection of itraconazole 125 approximately 200 mg bid for 2 days and then qd for at most 2 weeks and then oral administration of itraconazole 0.4 g/day for at most 2 weeks, and then the repeated regimen with a course of treatment of 1 approximately 3 months from 2002 to 2004. Eighteen cases were diagnosed with lung infection, 1 case with sinuses and trachea infection, and the infection sites were not documented for other 7 cases. The clinical results were analyzed. RESULTS: The effective rates of the patients with confirmed diagnosis, with clinical diagnosis, and with recommended diagnosis were 66.7% (4/6), 83.3% (10/12), and 14.3% (1/7) respectively. The effective rates of the patients with major imaging signs and those with secondary imaging signs were 90.0% (9/10) and 97.1% (4/7). There was a significant difference between the curative effects of the patients with confirmed diagnosis and those with recommended diagnosis (P = 0.006). CONCLUSION:
|
Authors | Jing-zhi Wang, Xiao-jun Huang, Kai-yan Liu, Dai-hong Liu, Huan Chen, Lan-ping Xu, Jin Lu, Yao-chen Zhang, Wei Han, Dao-pei Lu |
Journal | Zhonghua yi xue za zhi
(Zhonghua Yi Xue Za Zhi)
Vol. 85
Issue 21
Pg. 1481-3
(Jun 08 2005)
ISSN: 0376-2491 [Print] China |
PMID | 16061027
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antifungal Agents
- Itraconazole
|
Topics |
- Adolescent
- Adult
- Antifungal Agents
(therapeutic use)
- Candidiasis
(drug therapy, etiology)
- Child
- Female
- Hematologic Diseases
(complications, immunology)
- Humans
- Immunocompromised Host
- Injections, Intravenous
- Itraconazole
(therapeutic use)
- Male
- Middle Aged
- Mycoses
(drug therapy, etiology)
- Treatment Outcome
|